National Institute of Legal Medicine South Branch

Lisbon, Portugal

National Institute of Legal Medicine South Branch

Lisbon, Portugal
SEARCH FILTERS
Time filter
Source Type

Simoes S.S.,National Institute of Legal Medicine South Branch | Ajenjo A.C.,National Institute of Legal Medicine South Branch | Dias M.J.,National Institute of Legal Medicine South Branch
Rapid Communications in Mass Spectrometry | Year: 2011

A qualitative and quantitative analytical method was developed for the simultaneous determination of δ9-tetrahydrocannabinol (THC), 11-hydroxy-A9-tetrahydrocannabinol (11-OH-THC) and l1-nor-9-carboxy- δ9-tetrahydrocannabinol (THC-COOH) in whole blood. The samples were prepared by solid-phase extraction followed by ultra-performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) analysis using positive ion electrospray ionization and multiple reaction monitoring. The chromatographic separation was performed with an Acquity UPLC® HSS T3 (50 × 2.1 mm i.d., 1.8 μm) reversed-phase column using a methanol/2 mM ammonium formate (formic acid 0.1%) gradient in a total run time of 9.5 min. MS/MS detection was achieved with two precursor-product ion transitions per substance. The method was fully validated, including selectivity and capacity of identification, according to the identification criteria (two transitions per substance, signal-tonoise ratio, relative retention time and ion ratio) without the presence of interferences, limit of detection (0.2 μg/L for THC and 0.5 μg/L for 11-OH-THC and THC-COOH), limit of quantitation (0.5 μg/L for all cannabinoids), recovery (53-115%), carryover, matrix effect (34-43%), linearity (0.5-100 μg/L), intra-assay precision (CV < 10% for the relative peak area ratios and <0.1% for the relative retention time), inter-assay accuracy (mean relative error <10%) and precision (CV <11%). The method has already been successfully used in proficiency tests and subsequently applied to authentic samples in routine forensic analysis. Copyright © 2011 John Wiley & Sons, Ltd.


Simoes S.S.,National Institute of Legal Medicine South Branch | Ajenjo A.C.,National Institute of Legal Medicine South Branch | Dias M.J.,National Institute of Legal Medicine South Branch
Journal of Pharmaceutical and Biomedical Analysis | Year: 2012

Misoprostol is a pharmaceutical synthetic compound, analog of prostaglandin E1, frequently used as an abortifacient in not medically supervised or self-induced abortions, particularly in countries with restrictive abortion laws representing a serious public health problem. The aim of this study was to develop and validate a sensitive analytical method for the determination of misoprostol acid in whole blood samples. The samples were prepared by SPE and the chromatographic separation was performed by UPLC-MS/MS using ESI- and MRM mode with an Acquity UPLC® BEH C18 (50mm×2.1mm i.d., 1.7μm) column using a methanol-ammonium 0.1% solution gradient in a total run time of 7.0min. The method showed to be selective and linear in range 25-2000ng/L. The LOD and LOQ were 10ng/L and 25ng/L, respectively. The recovery ranged from 89 to 97%. No carryover and significant matrix effect were observed. The intra- and inter-assay precisions and the inter-assay accuracy results were 4.0% and 5.4%, 5.5% and 4.1%, and -1.4% and -2.8%, for the concentrations 50 and 500ng/L, respectively. The method developed allows the analysis of misoprostol acid in whole blood samples with adequate sensitivity to the concentration range obtained from therapeutic doses. The method was successfully used in a controlled misoprostol administration study and has been applied in our laboratory in the forensic toxicology field. © 2012 Elsevier B.V.


PubMed | National Institute of Legal Medicine South Branch
Type: | Journal: Journal of pharmaceutical and biomedical analysis | Year: 2012

Misoprostol is a pharmaceutical synthetic compound, analog of prostaglandin E1, frequently used as an abortifacient in not medically supervised or self-induced abortions, particularly in countries with restrictive abortion laws representing a serious public health problem. The aim of this study was to develop and validate a sensitive analytical method for the determination of misoprostol acid in whole blood samples. The samples were prepared by SPE and the chromatographic separation was performed by UPLC-MS/MS using ESI- and MRM mode with an Acquity UPLC() BEH C18 (50mm2.1mm i.d., 1.7m) column using a methanol-ammonium 0.1% solution gradient in a total run time of 7.0min. The method showed to be selective and linear in range 25-2000ng/L. The LOD and LOQ were 10ng/L and 25ng/L, respectively. The recovery ranged from 89 to 97%. No carryover and significant matrix effect were observed. The intra- and inter-assay precisions and the inter-assay accuracy results were 4.0% and 5.4%, 5.5% and 4.1%, and -1.4% and -2.8%, for the concentrations 50 and 500ng/L, respectively. The method developed allows the analysis of misoprostol acid in whole blood samples with adequate sensitivity to the concentration range obtained from therapeutic doses. The method was successfully used in a controlled misoprostol administration study and has been applied in our laboratory in the forensic toxicology field.

Loading National Institute of Legal Medicine South Branch collaborators
Loading National Institute of Legal Medicine South Branch collaborators